Bausch Health says annual revenue will exceed guidance, stock gains [MarketWatch]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: MarketWatch
Bausch Health Corp. shares gained more than 5% in after-hours trading Tuesday after the company announced that its annual revenue will come in higher than its guidance. Bausch Health, formerly known as Valeant Pharmaceuticals before a scandal that led to large-scale changes at the company, said that fourth-quarter revenue would top $2.2 billion and lead annual sales to come in higher than the top end of its guidance range, $8 billion. "We also expect a strong finish to the year with regard to Adjusted Ebitda,' Chief Executive Joseph Papa said in a statement, without providing any figures on profit. The disclosure arrived before Bausch executives speak Wednesday morning at the JP Morgan Healthcare Conference on recent accomplishments; full results are expected to be released next month. Bausch stock closed with a 0.1% decline at $23.47, and topped $25 in after-hours trades following the release of the information.
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research [Yahoo! Finance]Yahoo! Finance
- Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have a "sector perform" rating on the stock.MarketBeat
- Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033 [Yahoo! Finance]Yahoo! Finance
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards [Yahoo! Finance]Yahoo! Finance
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business AwardsPR Web
BHC
Earnings
- 2/22/24 - Miss
BHC
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEFA14A
- 4/4/24 - Form DEF
- BHC's page on the SEC website